MAFG and Thrombocytopenia: Gene targeting of MafF and MafK does not cause any apparent phenotype (124, 125), while MafG-null mice exhibit abnormal megakaryocyte differentiation and thrombocytopenia accompanied by a late-onset neurological disorder (145).